Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
PSP vs PSCH
Shared holdings
2
PSP covered by PSCH
22.29%
PSCH covered by PSP
22.29%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
PSP (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| Invesco Private Prime Fund | 16.24% | |
| Invesco Private Government Fund | 6.22% | |
| PARTNERS GROUP HOLDING AG COMMON STOCK | 4.13% | |
| CVC CAPITAL PART | 4.09% | |
| 3I GROUP PLC | 4.03% | |
| EQT AB /SEK/ 0.00000000 | 3.91% | |
| HAL Trust | 3.58% | |
| TPG INC | 3.43% | |
| BLACKSTONE INC | 3.36% | |
| SOFINA SA | 3.32% | |
| KKR & CO INC | 3.17% | |
| BLUE OWL CAPITAL INC A | 3.01% | |
| ONEX CORP | 2.38% | |
| EURAZEO SE | 2.15% | |
| CARLYLE GROUP INC (THE) | 2.14% | |
| COMMSTCK | 1.96% | |
| HAMILTON LANE INC - A | 1.70% | |
| STEPSTONE GROUP INC CLASS A | 1.70% | |
| HGCAPITAL TRUST PLC FUND | 1.63% | |
| SONAE | 1.53% | |
| WENDEL | 1.38% | |
| PANTHEON INTERNATIONAL PLC THE FUND | 1.37% | |
| Kinnevik AB, Class B | 1.36% | |
| BRIDGEPOINT GROUP PLC | 1.32% | |
| GRAHAM HOLDINGS CO | 1.22% | |
| GIMV NV | 1.00% | |
| HBM Healthcare Investments AG, Class A | 0.92% | |
| Schiehallion Fund Ltd. (The) | 0.89% | |
| Molten Ventures PLC | 0.81% | |
| MAIN STREET CAPITAL CORP COMMON STOCK USD.01 | 0.79% | |
| FAIRFAX INDI-SVS | 0.79% | |
| Oakley Capital Investments, Ltd. | 0.75% | |
| BROOKFIELD- CL A | 0.75% | |
| Blue Owl Technology Finance Corp. | 0.69% | |
| GEORGIA CAPITAL PLC | 0.69% | |
| COMMON STOCK | 0.68% | |
| BLUE OWL CAPITAL CORP COMMON STOCK | 0.67% | |
| Ratos AB, Class B | 0.62% | |
| ITALMOBILIARE SPA | 0.59% | |
| Jafco Group Co., Ltd. | 0.59% | |
| NB PRIVATE EQUITY PARTNERS LTD FUND | 0.58% | |
| IAC INC | 0.57% | |
| PATRIA INVS. LTD | 0.54% | |
| Mutares S.E. & Company KGaA | 0.44% | |
| COMPASS DIVERSIF | 0.43% | |
| Integral Corporation | 0.42% | |
| Alaris Equity Partners Income Trust | 0.42% | |
| PARTNERS GROUP PRIVATE EQUITY LTD | 0.38% | |
| IP Group PLC | 0.37% | |
| HERCULES CAPITAL INC | 0.37% |
PSCH (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| Invesco Private Prime Fund | 16.22% | |
| Invesco Private Government Fund | 6.07% | |
| KRYSTAL BIOTECH INC | 3.22% | |
| GLAUKOS CORP | 3.13% | |
| PTC THERAPEUTICS INC | 2.48% | |
| PROTAGONIST THERAPEUTICS INC | 2.45% | |
| TELEFLEX INC | 2.44% | |
| ALKERMES PLC | 2.25% | |
| TRANSMEDICS GROUP INC | 2.25% | |
| RADNET INC | 2.20% | |
| BRIGHTSPRING HEALTH SERVICES INC | 2.13% | |
| MERIT MEDICAL SYSTEMS INC | 2.07% | |
| TG THERAPEUTICS INC | 1.85% | |
| INDIVIOR PHARMACEUTICALS INC | 1.85% | |
| LIGAND PHARMACEUTICALS | 1.77% | |
| ICU MEDICAL INC | 1.68% | |
| ADMA BIOLOGICS INC | 1.68% | |
| CORCEPT THERAPEUTICS INC | 1.51% | |
| PRESTIGE CONSUMER HEALTHCARE INC | 1.51% | |
| SUPERNUS PHARMACEUTICALS INC | 1.42% | |
| ACADIA PHARMACEUTICALS INC | 1.39% | |
| INTEGER HOLDINGS CORP | 1.38% | |
| WAYSTAR HOLDING CORP | 1.33% | |
| VERACYTE INC | 1.31% | |
| CONCENTRA GROUP HOLDINGS PARENT INC | 1.29% | |
| PRIVIA HEALTH GROUP INC | 1.24% | |
| CATALYST PHARMACEUTICALS INC | 1.21% | |
| NEOGEN CORP | 1.11% | |
| AMNEAL PHARM INC | 1.06% | |
| LEMAITRE VASCULAR INC | 1.02% | |
| ACADIA HEALTHCARE CO INC | 0.98% | |
| APELLIS PHARMACEUTICALS INC | 0.97% | |
| NATL HEALTHCARE | 0.92% | |
| ORGANON & CO | 0.86% | |
| ADDUS HOMECARE CORP | 0.86% | |
| OMNICELL INC | 0.84% | |
| PERRIGO CO PLC | 0.82% | |
| VERICEL CORP | 0.82% | |
| SAREPTA THERAPEUTICS INC | 0.80% | |
| ARCUS BIOSCIENCES INC | 0.79% | |
| TANDEM DIABETES CARE INC | 0.78% | |
| INSPIRE MEDICAL SYSTEMS INC | 0.77% | |
| PEDIATRIX MEDICAL GROUP INC | 0.76% | |
| SELECT MEDICAL HLDGS CORP | 0.75% | |
| INNOVIVA INC | 0.74% | |
| UFP TECHNOLOGIES INC | 0.74% | |
| CORVEL CORP | 0.73% | |
| ARTIVION INC | 0.73% | |
| QUIDELORTHO CORP | 0.70% | |
| ENOVIS CORP | 0.66% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.